» Authors » Waldemar F Carlo

Waldemar F Carlo

Explore the profile of Waldemar F Carlo including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 40
Citations 201
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Watelle L, Toure M, Lamour J, Kemna M, Spinner J, Hoffman T, et al.
J Heart Lung Transplant . 2023 Mar; 42(8):1074-1081. PMID: 36997361
Background: Patients are usually maintained on at least 2 immunosuppressive drugs (ISDs) after the first year post heart transplant. Anecdotally, some children are switched to single-drug monotherapy (a single ISD)...
2.
Tan C, Cleveland D, Dabal R, Padilla L, Maxwell K, Law M, et al.
World J Pediatr Congenit Heart Surg . 2023 Feb; 14(1):25-30. PMID: 36847764
Background: Right ventricle (RV) to pulmonary artery (PA) shunts have become the shunt of choice at many centers for use during the Norwood procedure for single ventricle palliation. Some centers...
3.
Ale G, Simpson R, Mertens C, Santillana E, Hill B, Carlo W, et al.
Pediatr Pulmonol . 2023 Jan; 58(5):1607-1609. PMID: 36718986
No abstract available.
4.
Mantell B, Azeka E, Cantor R, Carlo W, Chrisant M, Dykes J, et al.
Pediatr Transplant . 2023 Jan; 27(5):e14456. PMID: 36591863
Background: Patients after Fontan palliation represent a growing pediatric population requiring heart transplant (HTx) and often have lymphopenia (L) and/or hypogammaglobinemia that may be exacerbated by protein-losing enteropathy (PLE, P)....
5.
Griffiths E, Lambert L, Ou Z, Shaaban A, Rezvani M, Carlo W, et al.
Pediatr Transplant . 2022 Nov; 27(2):e14435. PMID: 36380561
Background: Fontan associated liver disease (FALD) potentially impacts Fontan patients undergoing heart transplant. This multi-center study sought to identify pre-transplant risk factors and characterize any post-transplant liver recovery in those...
6.
Carlo W, Padilla L, Xu W, Carboni M, Kleinmahon J, Sparks J, et al.
J Heart Lung Transplant . 2022 Oct; 41(12):1773-1780. PMID: 36241468
Background: Black race is associated with worse outcomes across solid organ transplantation. Augmenting immunosuppression through antithymocyte globulin (ATG) induction may mitigate organ rejection and graft loss. We investigated whether racial...
7.
Litovsky S, Foote J, Jagdale A, Walcott G, Iwase H, Bikhet M, et al.
Ann Transplant . 2022 Jul; 27:e935338. PMID: 35789146
BACKGROUND Although improving, survival after pig orthotopic heart transplantation (OHTx) in baboons has been mixed and largely poor. The causes for the high incidence of early failure remain uncertain. MATERIAL...
8.
Cleveland D, Jagdale A, Carlo W, Iwase H, Crawford J, Walcott G, et al.
Ann Thorac Surg . 2021 Jun; 114(2):536-544. PMID: 34097894
Background: Mortality for infants on the heart transplant waitlist remains unacceptably high, and available mechanical circulatory support is suboptimal. Our goal is to demonstrate the feasibility of utilizing genetically engineered...
9.
Sisson T, Padilla L, Hubbard M, Smith S, Pearce F, Collins J, et al.
Clin Transplant . 2021 Apr; 35(6):e14314. PMID: 33838071
Background: Our pediatric heart transplant center transitioned from post-bypass basiliximab (BAS) induction to either anti-thymocyte globulin (ATG) or pre-bypass BAS. The purpose of this study was to compare first-year rejection...
10.
Urschel S, Ballweg J, Cantor R, Koehl D, Reinhardt Z, Zuckerman W, et al.
Lancet Child Adolesc Health . 2021 Mar; 5(5):341-349. PMID: 33743201
Background: ABO-incompatible heart transplantation increases donor availability in young children and is evolving into standard of care in children younger than 2 years. Previous smaller studies suggest similar outcomes to...